- D57.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D57.3 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D57.3 – other international versions of ICD-10 D57.3 may differ.
ICD-10-CM D57.3 is grouped within Diagnostic Related Group(s):
Applicable To
- Hb-S trait
- Heterozygous hemoglobin S
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D57.3:
- AS genotype > hemoglobin or Hb D58.2
- sickle-cell (sickling) (homozygous) > Disorder (of)
- heterozygous > sickle-cell (sickling) (homozygous) D57.3
- trait > sickle-cell (sickling) (homozygous) D57.3
- trait > sickle-cell (disease) D57.8-
- AS genotype > Hemoglobin
- S, heterozygous (Hb S) > Hemoglobin
- trait > Sickle-cell
- trait > Sicklemia
- Hb-S > Trait (s)
- S (Hb-S) > hemoglobin D58.2
- sickle-cell > Trait (s)
- with elliptocytosis or spherocytosis > sickle-cell D57.3